BMJ’s social innovations supplement to feature ColaLife’s pioneering work

ColaLife’s pioneering work on co-packaged ORS and Zinc is to be included in an upcoming BMJ special supplement on social innovations for health. Whilst the key aspects of ColaLife’s work were published online in 2016 as part of Rohit Ramchandani‘s DrPH thesis, it has always been a weakness that we’ve been unable to point to […]

Emulating Value Chains of Consumer Goods to Save Lives

Just before Christmas this independent academic analysis of our work was published by the prestigious IBM Center for The Business of Government. The work that went into this report was led by Paulo Savaget, a Gates Scholar completing his PhD at Cambridge University, who is now Assistant Professor at the University of Durham and a […]

Access to Medicines Conference, Geneva, 25-May-17

It was an honour to be asked to present the ColaLife Story at a conference in Geneva organised by Takeda on the subject of access to medicines. The presentation was very well received and was a reminder back to me of how much we’ve actually achieved and the hurdles we’ve overcome along the way. The […]

ColaLife’s work features strongly in Global ORS/Zinc Policy Paper

Open-source sharing of ColaLife’s lessons, designs and data has been our aspiration since we began in 2008. We’ve made a start on this (see our Open Access Initiative) but during 2016, we want to move this to the next level, even though work in Zambia to establish Kit Yamoyo in the market is still rolling […]

Report on trip to Janssen Pharmaceuticals, Beerse, Belgium

Last week (26-Aug-15) I visited the Janssen Pharmaceuticals HQ in Beerse, Belgium. I was invited jointly by Janssen and Johnson & Johnson to address the staff who work on the Beerse Campus at a ‘Townhall” event (200+ people). I also contributed to a Janssen Management Board Meeting and led a discussion with members of the […]

The 11 As for Access to ORS & Zinc for Under-5 Diarrhoea Treatment

Access to essential medicines is seen as the key barrier to health in developing countries, by governments and corporates alike[1]. The pharmaceutical industry and those involved in delivering patient healthcare often frame the issues surrounding ‘access’ as three – or sometimes four –  ‘As for Access’. ColaLife has looked at models of patient access covering, […]

The ColaLife Innovation Map – Take 2

I have written about the ColaLife Innovation Map before but it is time for an update. Peter Drucker, the late, famous American management consultant, educator, and author once said: “When a new venture does succeed, more often than not it is in a market other than the one it was originally intended to serve, with […]

It’s the value chain stupid!

Private sector people with supply chain experience will chuckle when they read this. It will be so obvious to them. But it’s not obvious to the rest of us. This is just one example of how public private partnerships are so helpful. What’s obvious to someone from the private sector may not be obvious to […]